Biosimilars as Effective as Reference Biologics for Cancer Treatment
The biosimilars proved as effective as the original biologics in all cancers studied.
The biosimilars proved as effective as the original biologics in all cancers studied.
A meta-analysis suggests that patients with cancer may be twice as likely as non-cancer patients to have a breakthrough infection after being fully vaccinated.